Transitional Cell Carcinoma of Renal Pelvis
2 clinical trials · Condition
◉ Watch Transitional Cell Carcinoma of Renal Pelvis
| Record | Firm | Date |
|---|---|---|
| The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study (NCT02793128) | UroGen Pharma Ltd. | 2017-04-04 |
Track Transitional Cell Carcinoma of Renal Pelvis automatically
Every clearance here is in the API, with alerts when new ones post.